Product Program year 2019 Source: CMS Open Payments

Mk-1242

Drug Cardiovascular

Open in the dashboard

General payments

$217,165

292 payments

Research payments

$10,628,366

871 payments

Through program year 2019, $217,165 in general payments and $10,628,366 in research payments were reported against Mk-1242 (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $217,165 292
2019 Research $10,628,366 871

Breakdown

Who paid General payments · program year 2019
  1. Merck Sharp & Dohme Corporation $217,165 292 payments
Top recipients General payments · program year 2019
  1. Christopher Oconnor Cardiovascular Disease · Falls Church, VA $61,185 28% · 26 payments
  2. Javed Butler Advanced Heart Failure and Transplant Cardiology · Jackson, MS $29,648 14% · 26 payments
  3. Jose Vazquez-Tanus Cardiovascular Disease · Doral, FL $17,807 8% · 17 payments
  4. Ileana Pina Advanced Heart Failure and Transplant Cardiology · Philadelphia, PA $17,326 8% · 23 payments
  5. Adrian Hernandez Cardiovascular Disease · Durham, NC $10,954 5% · 24 payments

The top 5 of 36 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Cardiovascular Disease Internal Medicine $147,830 68% · 17 practitioners
  2. Advanced Heart Failure and Transplant Cardiology Internal Medicine $57,520 26% · 10 practitioners
  3. Internal Medicine $7,142 3% · 3 practitioners
  4. Vascular Surgery Surgery $1,477 <1% · 1 practitioner
  5. Interventional Cardiology Internal Medicine $1,393 <1% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. North Carolina $79,832 37% · 5 recipients
  2. Puerto Rico $34,219 16% · 3 recipients
  3. Mississippi $30,402 14% · 2 recipients
  4. Massachusetts $20,526 9% · 4 recipients
  5. Michigan $17,966 8% · 2 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

292 general · 871 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record